Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Global Implantable Cardioverter Defibrillators Market by Product Type, by Type, by NYHA Class, by End-User, and By Region" report has been added to ...

The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...

The use of life-saving implantable cardioverter defibrillators in Canada is rising, but it is still significantly less than that in the United States. Dr. David Birnie and colleagues from the ...

Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large ...

Implantable cardioverter defibrillators are devices implanted in a patient’s chest with the ability to terminate ventricular arrhythmias. Termination of these ventricular arrhythmias is vital to ...

Short- and long-term risks of ventricular tachycardia or ventricular fibrillation, and of recurrent events, are related to the presence of transient or persistent physiological factors. Ventricular ...

Patients with left ventricular systolic dysfunction are at risk of ventricular arrhythmias and sudden cardiac death. Meta-analyses of randomized controlled trials (RCTs) have demonstrated that, in ...

Boston Scientific Shockless Implant Evaluation (SIMPLE) Study Results Presented at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions The trial results demonstrated that ...

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval and launch of the DF4 High-Voltage Connector System, a right ventricular ...

St. Louis Blues defenseman Jay Bouwmeester, who needed a defibrillator to be revived after suffering a cardiac episode on the team bench during a game, has undergone a successful Implantable ...